{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:07:44Z","timestamp":1773112064393,"version":"3.50.1"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274582"],"award-info":[{"award-number":["82274582"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Hebei Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["H2019106063"],"award-info":[{"award-number":["H2019106063"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hebei Province Innovation Capability Improvement Plan project","award":["20577715D"],"award-info":[{"award-number":["20577715D"]}]},{"DOI":"10.13039\/501100005064","name":"S&T Program of Hebei","doi-asserted-by":"publisher","award":["19277701D"],"award-info":[{"award-number":["19277701D"]}],"id":[{"id":"10.13039\/501100005064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n<jats:title>Background::<\/jats:title>\n<jats:p>Early diagnosis remains difficult because the early symptoms of thymoma\nare atypical.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective::<\/jats:title>\n<jats:p>This study aimed to analyze the changes of serum proteins in the early stage of thymoma\n(stage I\/II) by proteomics method and to screen and validate candidate biomarkers.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods::<\/jats:title>\n<jats:p>Proteins were extracted from 8 sera patients with stage I\/II thymoma and 9 healthy controls.\nThe levels of serum proteins were detected by data-independent acquisition (DIA) quantitative\nproteomics techniques, and the differential proteins were identified. The proteomic results\nwere verified by enzyme-linked immunosorbent assay. Additionally, differentially expressed proteins\nwere analyzed using receiver operating characteristic curves (ROC).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results::<\/jats:title>\n<jats:p>There were 80 differentially expressed proteins between the patients with thymoma and\nthe healthy control group, among which 39 were up-regulated and 41 were down-regulated. Differential\nprotein enrichment is involved in environmental information processing, signaling\nmolecules and interactions, and in the body system and the immune system. The analysis of receptor\nworking characteristic curves showed that the areas under the curve of CORO1A, SAA1 and\nLTA4H were all larger than 0.8, indicating that these proteins had good diagnostic value.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion::<\/jats:title>\n<jats:p>CORO1A, SAA1 and LTA4H may be new biomarkers for early screening of thymoma.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298665275655231103105924","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T11:06:39Z","timestamp":1701947199000},"page":"74-83","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring Potential Biomarkers of Early Thymoma based on Serum\nProteomics"],"prefix":"10.2174","volume":"31","author":[{"given":"Min","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Oncology, Hebei Medical University, Hebei, China"},{"name":"People's Hospital of Shijiazhuang Affiliated to Hebei Medical University, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[{"name":"People's Hospital of Shijiazhuang Affiliated to Hebei Medical University, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9218-3219","authenticated-orcid":true,"given":"Guoyan","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hebei Medical University, Hebei, China"},{"name":"People's Hospital of Shijiazhuang Affiliated to Hebei\nMedical University, Hebei, China"},{"name":"Hebei Provincial Key Laboratory of Myasthenia Gravis, Hebei, China"},{"name":"Hebei\nProvincial Clinical Research Center for Myasthenia Gravis, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.semdp.2021.06.002","volume":"39","author":"Oramas D.M.","year":"2022","unstructured":"Oramas D.M.; Moran C.A.; Thymoma: Histologically a heterogenous group of tumors. Semin Diagn Pathol  2022,39(2),99-104","journal-title":"Semin Diagn Pathol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1746-1596-7-120","volume":"7","author":"Ma Y.","year":"2012","unstructured":"Ma Y.; Li Q.; Cui W.; Miao N.; Liu X.; Zhang W.; Zhang C.; Wang J.; Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: Relationship with the current WHO classification systems. Diagn Pathol  2012,7(1),120","journal-title":"Diagn Pathol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00428-011-1041-x","volume":"458","author":"Kaira K.","year":"2011","unstructured":"Kaira K.; Murakami H.; Serizawa M.; MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma J. Virchows Archiv  2011,458(5),615-20","journal-title":"Virchows Archiv"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.immuni.2018.12.030","volume":"50","author":"Ford M.L.","year":"2019","unstructured":"Ford M.L.; Coronin-1, king of alloimmunity. Immunity  2019,50(1),3-5","journal-title":"Immunity"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/1568009043333041","volume":"4","author":"Chen X.","year":"2004","unstructured":"Chen X.; Wang S.; Wu N.; Yang C.; Leukotriene A4 hydrolase as a target for cancer prevention and therapy. Curr Cancer Drug Targets  2004,4(3),267-283","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nyas.13929","volume":"1431","author":"Vo T.T.L.","year":"2018","unstructured":"Vo T.T.L.; Jang W.J.; Jeong C.H.; Leukotriene A4 hydrolase: An emerging target of natural products for cancer chemoprevention and chemotherapy. Ann N Y Acad Sci  2018,1431(1),3-13","journal-title":"Ann N Y Acad Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"Ashburner M.","year":"2000","unstructured":"Ashburner M.; Ball C.A.; Blake J.A.; Botstein D.; Butler H.; Cherry J.M.; Davis A.P.; Dolinski K.; Dwight S.S.; Eppig J.T.; Harris M.A.; Hill D.P.; Issel-Tarver L.; Kasarskis A.; Lewis S.; Matese J.C.; Richardson J.E.; Ringwald M.; Rubin G.M.; Sherlock G.; Gene Ontology: Tool for the unification of biology. Nat Genet  2000,25(1),25-29","journal-title":"Nat Genet"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkm882","volume":"36","author":"Kanehisa M.","year":"2008","unstructured":"Kanehisa M.; Araki M.; Goto S.; Hattori M.; Hirakawa M.; Itoh M.; Katayama T.; Kawashima S.; Okuda S.; Tokimatsu T.; Yamanishi Y.; KEGG for linking genomes to life and the environment. Nucleic Acids Res  2008,36(Database issue),D480-D484","journal-title":"Nucleic Acids Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"Szklarczyk D.","year":"2019","unstructured":"Szklarczyk D.; Gable A.L.; Lyon D.; Junge A.; Wyder S.; Huerta-Cepas J.; Simonovic M.; Doncheva N.T.; Morris J.H.; Bork P.; Jensen L.J.; Mering C.; STRING v11: Protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res  2019,47(D1),D607-D613","journal-title":"Nucleic Acids Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1038\/s41598-023-32339-4","volume":"13","author":"Li J.","year":"2023","unstructured":"Li J.; Qi G.; Liu Y.; Proteomics analysis of serum from thymoma patients. Sci Rep  2023,13(1),5117","journal-title":"Sci Rep"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2174\/1389203717666151201192011","volume":"17","author":"Liu X.","year":"2016","unstructured":"Liu X.; Gao Y.; Lin X.; Li L.; Han X.; Liu J.; The coronin family and human disease. Curr Protein Pept Sci  2016,17(6),603-611","journal-title":"Curr Protein Pept Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/prca.200800167","volume":"3","author":"Kim D.H.","year":"2009","unstructured":"Kim D.H.; Bae J.; Lee J.W.; Kim S.Y.; Kim Y.H.; Bae J.Y.; Yi J.K.; Yu M.H.; Noh D.Y.; Lee C.; Proteomic analysis of breast cancer tissue reveals upregulation of actin-remodeling proteins and its relevance to cancer invasiveness. Proteomics Clin Appl  2009,3(1),30-40","journal-title":"Proteomics Clin Appl"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"13539","DOI":"10.18632\/oncotarget.3841","volume":"6","author":"Kumar P.","year":"2015","unstructured":"Kumar P.; Nandi S.; Tan T.Z.; Ler S.G.; Chia K.S.; Lim W.Y.; B&#xFC;tow Z.; Vordos D.; De laTaille A.; Al-Haddawi M.; Raida M.; Beyer B.; Ricci E.; Colombel M.; Chong T.W.; Chiong E.; Soo R.; Park M.K.; Ha H.K.; Gunaratne J.; Thiery J.P.; Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma. Oncotarget  2015,6(15),13539-13549","journal-title":"Oncotarget"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3109\/1061186X.2014.888072","volume":"22","author":"Xu X.J.","year":"2014","unstructured":"Xu X.J.; Tang Y.M.; Zhao H.Z.; Guo L.; Wang Z.J.; ZCH-2B8a, an antibody targeting actin-binding protein coronin-1a, is a potential therapeutic agent for B-lineage malignancies. J Drug Target  2014,22(6),488-497","journal-title":"J Drug Target"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/cancers12082032","volume":"12","author":"Rumi Higuchi T.G.Y.H.","year":"2020","unstructured":"Rumi Higuchi T.G.Y.H.; Primary driver mutations in GTF2I specific to the development of thymomas. Cancers  2020,12(8),2032","journal-title":"Cancers"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1194\/jlr.R067314","volume":"57","author":"Schmidt K.","year":"2016","unstructured":"Schmidt K.; Noureen A.; Kronenberg F.; Utermann G.; Structure, function, and genetics of lipoprotein (a). J Lipid Res  2016,57(8),1339-1359","journal-title":"J Lipid Res"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"Gabay C.","year":"1999","unstructured":"Gabay C.; Acute-phase proteins and other systemic responses to inflammation. N Engl J Med  1999,340(6),448-458","journal-title":"N Engl J Med"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.155.3.1184","volume":"155","author":"Xu L.","year":"1995","unstructured":"Xu L.; Badolato R.; Murphy W.J.; A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J immun  1995,155(3),1184-1190","journal-title":"J immun"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/eji.201444818","volume":"45","author":"Gouwy M.","year":"2015","unstructured":"Gouwy M.; De Buck M.; P&#xF6;rtner N.; Opdenakker G.; Proost P.; Struyf S.; Van Damme J.; Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines. Eur J Immunol  2015,45(1),101-112","journal-title":"Eur J Immunol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"649761","DOI":"10.3389\/fonc.2021.649761","volume":"11","author":"Li S.","year":"2021","unstructured":"Li S.; Cheng Y.; Cheng G.; Xu T.; Ye Y.; Miu Q.; Cao Q.; Yang X.; Ruan H.; Zhang X.; High SAA1 expression predicts advanced tumors in renal cancer. Front Oncol  2021,11,649761","journal-title":"Front Oncol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1111\/cas.14866","volume":"112","author":"Ren H.","year":"2021","unstructured":"Ren H.; He G.; Lu Z.; He Q.; Li S.; Huang Z.; Chen Z.; Cao C.; Wang A.; Retracted: arecoline induces epithelial- mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression. Cancer Sci  2021,112(6),2173-2184","journal-title":"Cancer Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.7150\/jca.48419","volume":"12","author":"Zhang H.","year":"2021","unstructured":"Zhang H.; Xu Y.; Deng G.; Yuan F.; Tan Y.; Gao L.; Sun Q.; Qi Y.; Yang K.; Geng R.; Jiang H.; Liu B.; Chen Q.; SAA1 knockdown promotes the apoptosis of glioblastoma cells via downregulation of AKT signaling. J Cancer  2021,12(9),2756-2767","journal-title":"J Cancer"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1099271","DOI":"10.3389\/fonc.2022.1099271","volume":"12","author":"Shu Z.","year":"2022","unstructured":"Shu Z.; Guo J.; Xue Q.; Tang Q.; Zhang B.; Single-cell profiling reveals that SAA1+ epithelial cells promote distant metastasis of esophageal squamous cell carcinoma. Front Oncol  2022,12,1099271","journal-title":"Front Oncol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1002\/pmic.200401205","volume":"5","author":"Moshkovskii S.A.","year":"2005","unstructured":"Moshkovskii S.A.; Serebryakova M.V.; Kuteykin-Teplyakov K.B.; Tikhonova O.V.; Goufman E.I.; Zgoda V.G.; Taranets I.N.; Makarov O.V.; Archakov A.I.; Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. Proteomics  2005,5(14),3790-3797","journal-title":"Proteomics"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1189\/jlb.3A0315-085R","volume":"98","author":"Mieke De Buck N.B.N.P.","year":"2015","unstructured":"Mieke De Buck N.B.N.P.; Serum amyloid A1a induces paracrine IL-8\/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils. J Leukoc Biol  2015,98(6),1049-1060","journal-title":"J Leukoc Biol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1038\/s41467-020-18697-x","volume":"11","author":"Gao S.","year":"2020","unstructured":"Gao S.; Jiang J.; Jin C.; Gao J.; Xiong D.; Yang P.; Cui S.; Yang W.; Leng Q.; Dong J.; Chen G.; Liu J.; Wang L.; Ke A.; Wang H.; Ding J.; Interleukin-8 as a candidate for thymoma identification and recurrence surveillance. Nat Commun  2020,11(1),4881","journal-title":"Nat Commun"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e14875","DOI":"10.7717\/peerj.14875","volume":"11","author":"Ren T.","year":"2023","unstructured":"Ren T.; Wang S.; Zhang B.; Zhou W.; Wang C.; Zhao X.; Feng J.; LTA4H extensively associates with mRNAs and lncRNAs indicative of its novel regulatory targets. PeerJ  2023,11,e14875","journal-title":"PeerJ"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1016\/j.jid.2021.03.032","volume":"141","author":"Zhao S.","year":"2021","unstructured":"Zhao S.; Yao K.; Liu K.; Huang L.; Jiang Y.; Li J.; Dong Z.; Dong Z.; Bestatin cream impairs solar simulated light\u2012driven skin inflammation and skin carcinogenesis in mice. J Invest Dermatol  2021,141(11),2699-2709.e2","journal-title":"J Invest Dermatol"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665275655231103105924","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/224160\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665275655231103105924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T17:07:45Z","timestamp":1713373665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/224160\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298665275655231103105924","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-08-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}